SEC Form 4 · accession 0001910132-26-000007
SPRUCE BIOSCIENCES, INC. · SPRB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adrian W Quartel
Officer — Chief Medical Officer
Period of report
Jul 27, 2026
Accepted (ET)
Jul 29, 2026 · 4:10 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001683553
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | $0.00 | Jul 27, 2026 | A | 13,000 | A | — | — | Common Stock | 13,000 | 13,000 | D |
Explanation of responses
- F1Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- F225% of the total number of restricted stock units ("RSUs") will vest on June 15, 2027. 25% of the total number of RSUs will vest on each of June 15, 2028, June 15, 2029 and June 15, 2030, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date.